Product approvals

March 21, 2017 - 5:05 pm
U.S. regulators have approved the first new drug in a decade for Parkinson's disease, a neurological disorder that causes tremors and movement difficulties. The Food and Drug Administration says it has approved Xadago (Zah-DAH'-goh) for use when a patient's regular medicines aren't working well...
Read More
FILE - In a Saturday, Aug. 13, 2016 file photo, logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea. U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer. The drug, called Kisqali, developed by Swiss drugmaker Novartis, is a pill that works to slow the spread of cancer by blocking two proteins that can stimulate growth and division of cancer cells. (AP Photo/Ahn Young-joon, File)
March 13, 2017 - 7:28 pm
TRENTON, N.J. (AP) — U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer. The drug, called Kisqali and developed by Swiss drugmaker Novartis AG, is a pill that works to slow the spread of cancer by blocking two proteins...
Read More
FILE - In this June 11, 2009 file photo, Dr. Scott Gottlieb, left, is seen on Capitol Hill in Washington. A White House official says President Donald Trump is choosing Gottlieb, a conservative doctor-turned-pundit with deep ties to Wall Street and the pharmaceutical industry to lead the powerful Food and Drug Administration (FDA). (AP Photo/Harry Hamburg, File)
March 11, 2017 - 2:55 am
WASHINGTON (AP) — A conservative doctor-turned-pundit with deep ties to Wall Street and the pharmaceutical industry is President Donald Trump's pick to lead the Food and Drug Administration. Dr. Scott Gottlieb would be tasked with Trump's goal of cutting red tape at the FDA, which regulates...
Read More
FILE - In this June 11, 2009 file photo, Dr. Scott Gottlieb, left, is seen on Capitol Hill in Washington. A White House official says President Donald Trump is choosing Gottlieb, a conservative doctor-turned-pundit with deep ties to Wall Street and the pharmaceutical industry to lead the powerful Food and Drug Administration (FDA). (AP Photo/Harry Hamburg, File)
March 10, 2017 - 4:48 pm
WASHINGTON (AP) — President Donald Trump is choosing a conservative doctor-turned-pundit with deep ties to Wall Street and the pharmaceutical industry to lead the powerful Food and Drug Administration, a White House official said Friday. Dr. Scott Gottlieb would be tasked with Trump's goal of...
Read More

Pages